Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.

MLA

Wasik, M. A., et al. “Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma. Clinical and Prognostic Implications.” Archives of Dermatology, vol. 132, no. 1, Jan. 1996, pp. 42–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8546482&authtype=sso&custid=ns315887.

APA

Wasik, M. A., Vonderheid, E. C., Bigler, R. D., Marti, R., Lessin, S. R., Polansky, M., & Kadin, M. E. (1996). Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Archives of Dermatology, 132(1), 42–47.

Chicago

Wasik, M A, E C Vonderheid, R D Bigler, R Marti, S R Lessin, M Polansky, and M E Kadin. 1996. “Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma. Clinical and Prognostic Implications.” Archives of Dermatology 132 (1): 42–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8546482&authtype=sso&custid=ns315887.